| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | President and CEO | Chief Operating Officer
2 companies
Ciaffoni Joseph serves as a Chief Executive Officer at INDV and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 40 sells. Those positions are worth an estimated $30.3M at current prices.
Historically, Ciaffoni Joseph's trades have earned a below-average insider score of 43/100 across 23 rated trades. Over a 12-month horizon, 13.0% of those trades were profitable, with an average 12-month return of -20.3%.
The biggest single holding is INDV (~$30.3M) as Chief Executive Officer.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2022 | COLL Collegium Pharmaceutical, Inc | President and CEO | Sale+OE | 1,989 | $22.02 | $43,797.78 | -0.6% | +21.3% | +14.8% | |
| Mar 1, 2022 | COLL Collegium Pharmaceutical, Inc | President and CEO | Sell | 76,094 | $18.47 | $1,405,224.15 | -19.0% | -15.6% | +44.7% | |
| Jun 2, 2021 | COLL Collegium Pharmaceutical, Inc | President and CEO | Sale+OE | 22,066 | $23.09 | $509,601.66 | -7.6% | -9.9% | -31.2% | |
| Mar 1, 2021 | COLL Collegium Pharmaceutical, Inc | President and CEO | Sale+OE | 64,768 | $22.67 | $1,468,424.74 | -18.9% | - | - | |
| Jun 2, 2020 | COLL Collegium Pharmaceutical, Inc | President and CEO | Sale+OE | 76,537 | $21.45 | $1,641,766.95 | -28.4% | - | - | |
| Nov 7, 2019 | COLL Collegium Pharmaceutical, Inc | President and CEO | Sale+OE | 64,821 | $18.77 | $1,216,774.11 | -26.8% | - | - | |
| Jun 3, 2019 | COLL Collegium Pharmaceutical, Inc | President and CEO | Sell | 13,287 | $11.56 | $153,586.76 | -6.9% | - | - | |
| Jun 1, 2018 | COLL Collegium Pharmaceutical, Inc | Chief Operating Officer | Sale+OE | 79,683 | $22.59 | $1,799,712.87 | -47.5% | - | - |